moxisylyte has been researched along with ibopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galbiati, I; Gazzaniga, A; Gianesello, V; Soldati, L; Virno, M | 1 |
| Barbieri, P; Dal Bello, A; Drago, F; Lodola, E; Marino, V; Pisati, R | 1 |
1 trial(s) available for moxisylyte and ibopamine
| Article | Year |
|---|---|
Evaluation of the effect of thymoxamine solution 0.5% on mydriasis induced by ibopamine solution 1%.
Topics: Adult; Aged; Deoxyepinephrine; Eye Color; Eye Diseases; Female; Humans; Male; Middle Aged; Moxisylyte; Mydriatics; Pupil | 1993 |
1 other study(ies) available for moxisylyte and ibopamine
| Article | Year |
|---|---|
Ocular pharmacokinetics and pharmacodynamics in rabbits of ibopamine, a new mydriatic agent.
Topics: Adrenergic alpha-Agonists; Animals; Aqueous Humor; Deoxyepinephrine; Dose-Response Relationship, Drug; Female; Male; Moxisylyte; Mydriatics; Pupil; Quinazolines; Rabbits; Reserpine; Swine; Time Factors | 1993 |